Nivolumab for previously treated gastric or gastro-oesophageal junction cancer [ID1118]
Discontinued
Reference number: GID-TA10151
Following on from advice received from the company this appraisal has been rescheduled to align with latest regulatory expectations. Therefore, the deadline for submissions is now expected in approximately late November 2017.